2025 annual financial data
Ironwood Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was 40.1%.
Operating income was 118,759,000 USD and net income was 24,017,000 USD.
Operating cash flow was 127,044,000 USD.
Get free Ironwood Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 296,151,000 USD
- Operating income
- 118,759,000 USD
- Net income
- 24,017,000 USD
- Operating cash flow
- 127,044,000 USD